Press Releases

Trust Bio-sonics Completes Final Patient Enrollment for Phase III Trial of TBS-002 Ultrasound Contrast Agent

12/17/2025

Date: 2025/ 12/ 17 Wed., Media: Global Bio & Investment

Trust Bio-sonics’ Lipid Microsphere Platform: Paving New Paths to Overcome Hard-to-Treat Cancers

07/17/2025

Date: 2025/ 7/ 17 Thu., Media: Global Bio & Investment

Trust Bio-sonics' Ultrasound Enhancing Agent has Completed the Enrollment of the First Patient in its Phase III Study

03/20/2025

Date: 2025/ 3/ 20 Thu., Media: Global Bio & Investment

Taiwanese Manufacturers Dive into the Ultrasound Medical Market - A Comprehensive Overview

03/03/2025

Date: 2025/ 3/ 3 Mon., Media: Global Bio & Investment

Science Park approved 8 investment projects with a total amount of over NT$3.3 billion

02/26/2025

Date: 2025/ 2/ 26 Wed., Media: Economic Daily News

Hidden Champion / Trust Bio-sonics, Precision Diagnostics + Drug Delivery

11/24/2024

Date: 2024/ 11/ 24 Sun., Media: Economic Daily News

2024 BIO Company News - Trust Bio-sonics Elected as the Finalist of Start-Up Stadium: Ultrasound Drug Delivery Technology Increases Pancreatic Cancer Survival Rate by 3 Times

06/07/2024

Date: 2024/ 6/ 7 Fri., Media: Global Bio & Investment